ROCK2-IN-10

CAS No. 1072906-07-0

ROCK2-IN-10( —— )

Catalog No. M37666 CAS No. 1072906-07-0

Benzenamine, 2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)- is a useful organic compound for research related to life sciences.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 185 In Stock
10MG 271 In Stock
25MG 427 In Stock
50MG 559 In Stock
100MG 749 In Stock
200MG 1014 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ROCK2-IN-10
  • Note
    Research use only, not for human use.
  • Brief Description
    Benzenamine, 2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)- is a useful organic compound for research related to life sciences.
  • Description
    Benzenamine, 2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)- is a useful organic compound for research related to life sciences. The catalog number is T9797 and the CAS number is 1072906-07-0.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1072906-07-0
  • Formula Weight
    246.31
  • Molecular Formula
    C13H18N4O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N1=CC(=CN1)C=2C=CC(N)=C(OCCN(C)C)C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (R)-ZINC-3573

    (R)-ZINC-3573 is a potent and highly selective MRGPRX2 probe that activates endogenous MRGPRX2 in a human mast cell line, inducing degranulation and calcium release.

  • AD 01

    FKBPL (FK506-binding protein like)-based peptide. Binds to and upregulates expression of CD44. Inhibits breast cancer stem cell (BCSC) growth. Decreases pluripotency markers and promotes differentiation of BCSCs. Also inhibits endothelial cell migration as well as tubule and microvessel formation in vitro and in vivo. Blocks tumor growth in xenograft models.

  • Isoxepac

    Isoxepac is a non-steroidal anti-antiphlogistic agent and analgesic.